Moreover, in recent reports CD39 expression in CD8+ TILs was described as a marker for tumor-antigen specific TILs that have undergone tumor-antigen-driven clonal expansion, exhibit resident memory T cell-like phenotypes and express a variety of co-stimulatory and co-inhibitory receptors [40,41,42]. The gene discussed is ENTPD1; the disease is neoplasm.